BioCentury
ARTICLE | Clinical News

Anti-CD19 chimeric antigen receptor: Updated Phase I data

June 20, 2016 7:00 AM UTC

Data from 22 patients with DLBCL, follicular lymphoma or mantle cell lymphoma (MCL) in an open-label, U.S. Phase I trial showed that a single infusion of anti- CD19 CAR T cells given 2 days after comp...